+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Ginsenoside Rd

BP0661
52705-93-8
98%
Biopurify
Ginsenoside Rd, a minor ginseng saponin, has several pharmacological activities such as immunosuppressive activity, anti-inflammatory activity, immunological adjuvant, anti-cancer activity and wound-healing activity. Rd inhibits TNFα-induced NF-κB transcriptional activity with an IC50 of 12.05±0.82 μM in HepG2 cells. Rd inhibits expression of COX-2 and iNOS mRNA. Rd also inhibits Ca2+ influx. Rd inhibits CYP2D6, CYP1A2, CYP3A4, and CYP2C9, with IC50s of 58.0±4.5 μM, 78.4±5.3 μM, 81.7±2.6 μM, and 85.1±9.1 μM, respectively. Ginsenoside Rd is a ginsenoside found in Panax ginseng and Panax japonicus var. major that is (20S)-ginsenoside Rg3 in which the hydroxy group at position 20 has been converted to its beta-D-glucopyranoside. It has a role as an anti-inflammatory drug, an immunosuppressive agent, a neuroprotective agent, an apoptosis inducer, a vulnerary and a plant metabolite. It is a beta-D-glucoside, a tetracyclic triterpenoid and a ginsenoside. It is functionally related to a (20S)-ginsenoside Rg3.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0661-20mg 20mg
BP0661-100mg 100mg
BP0661-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

BACE1 TNF NOS2 PTGS2 NFKB1 CACNA1C
TRPV1 TNF NOS2 PTGS2 NFKB1 CYP3A4
BACE1 MAPT SNCA CACNA1C APOE PSEN1
CYP3A4 CYP1A2

Ginsenoside Rd Related Products

Product drug property prediction parameters

  • 298.1400

  • 2.4782

  • 2.4780

  • .1105

  • .4896

  • .1440

  • Low

  • 71.4485

  • 6.3768

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No